Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001179110-22-000395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-11 | 2022-01-07 | PTCT | Pauwels Eric | Chief Business Off | A - Grant | $0.00 | +16.8K | 51.3K | +49% | $0 |
| D | 2022-01-11 | 2022-01-07 | PTCT | Pauwels Eric | Chief Business Off | S - Sale | $38.53 | -866 | 34.5K | -2% | -$33.4K |
| D | 2022-01-11 | 2022-01-07 | PTCT | Pauwels Eric | Chief Business Off | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | A | A | 16,800 | $0.00 | 51,320 | D | — | — | (F2) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. |
| 2 | Common | Common Stock | 2022-01-07 | S | D | 866 | $38.53 | 34,520 | D | — | — | (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-01-07 | A | A | 63,000 | $0.00 | 63,000 | D | $38.10 · — to 2032-01-06 | 63,000 Common Stock | (F3) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. |